Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literature.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 24, 2014
Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
Journal: Journal of drugs in dermatology : JDD
Published: October 03, 2013
Showing 1-3 of 3
Last Updated: 09/26/2026